Rockland Immunochemicals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Rockland Immunochemicals

Access the complete profile.

Rockland Immunochemicals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325414 Biological Product Manufacturing 5411 Legal Services
Address	321 Jones Blvd Pottstown, PA 19464

Note: Revenues for privately held companies are statistical evaluations.


Rockland Immunochemicals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Rockland Immunochemicals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Rockland Immunochemicals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Rockland Immunochemicals Annual Revenue and Growth Rate

Rockland Immunochemicals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Rockland Immunochemicals's revenues are gauged from an analysis of company filings.

Rockland Immunochemicals's Income Statement (based on Industry Averages)

Rockland Immunochemicals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Rockland Immunochemicals is developing and marketing. Rockland Immunochemicals doesn't have any recent trademark applications, indicating Rockland Immunochemicals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EPI-PLUS Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use	07/08/2011

See all trademarks and details in the Full Report.

Market Share of Rockland Immunochemicals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rockland Immunochemicals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Rockland Immunochemicals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PSI PHARMA SUPPORT AMERICA	King Of Prussia, PA	100
INOVIO PHARMACEUTICALS	Plymouth Meeting, PA	38
TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS	Blue Bell, PA	37
ROCKLAND IMMUNOCHEMICALS	Pottstown, PA	30
MADRIGAL PHARMACEUTICALS	West Conshohocken, PA	26
ZEROEYES	Conshohocken, PA	22

Future Competition: Rockland Immunochemicals's Fastest Growing Competitors

These companies are in the same general field as Rockland Immunochemicals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)